Published in Mediators Inflamm on March 17, 2013
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies. Oncogene (2015) 0.92
MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer. Mol Cancer (2015) 0.89
Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev (2014) 0.84
Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration. PLoS One (2016) 0.77
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation. Sci Rep (2017) 0.75
Effect of Periodic Granulocyte Colony-Stimulating Factor Administration on Endothelial Progenitor Cells and Different Monocyte Subsets in Pediatric Patients with Muscular Dystrophies. Stem Cells Int (2015) 0.75
Effect of CD16a, the surface receptor of Kupffer cells, on the growth of hepatocellular carcinoma cells. Int J Mol Med (2016) 0.75
Differential distribution of tumor-associated macrophages and Treg/Th17 cells in the progression of malignant and benign epithelial ovarian tumors. Oncol Lett (2016) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
NF-kappaB regulation in the immune system. Nat Rev Immunol (2002) 15.80
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med (1998) 12.80
The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol (2004) 10.85
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol (1995) 10.61
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med (2001) 9.99
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov (2004) 9.96
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell (2009) 8.54
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol (2002) 8.27
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56
Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (1989) 7.30
DNA damage and repair. Nature (2003) 6.76
Nomenclature of monocytes and dendritic cells in blood. Blood (2010) 6.63
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 6.60
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol (2009) 5.55
The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol (2006) 5.50
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res (1996) 5.38
MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell (2002) 4.93
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol (2009) 4.53
"Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med (2008) 4.38
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res (2005) 4.33
Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med (2003) 4.02
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res (2000) 3.86
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol (2002) 3.75
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev (2010) 3.56
Toll-like receptor signaling. J Biol Chem (2003) 3.24
Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev (2002) 2.86
Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med (1992) 2.84
Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol (2005) 2.81
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood (2007) 2.74
The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood (1993) 2.62
Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol (2001) 2.56
Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct (2001) 2.48
Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood (2001) 2.39
Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res (2006) 2.37
Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn (2006) 2.35
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res (2002) 2.13
Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science (1998) 2.13
CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol (2004) 2.11
Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol (2006) 2.08
Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta (2009) 2.05
Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol (2008) 1.99
Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res (1999) 1.93
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol (2004) 1.88
Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood (1999) 1.88
Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res (2000) 1.84
Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today (1996) 1.82
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol (1998) 1.81
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J (2009) 1.80
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer (2003) 1.80
Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol (2007) 1.79
Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol (1995) 1.74
Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer (2007) 1.70
Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol (2001) 1.68
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract (1998) 1.60
The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res (2004) 1.55
VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. J Cell Sci (2003) 1.46
Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol (2002) 1.42
The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today (1997) 1.34
Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci (2007) 1.32
Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol (1996) 1.30
Chemokines in tumor progression and metastasis. Cancer Sci (2005) 1.29
Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun (1998) 1.24
Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas? Eur J Cancer (2001) 1.21
Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J Immunol (2000) 1.21
Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol (2002) 1.17
CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood (1995) 1.16
Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer (1996) 1.15
T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut (1997) 1.14
A novel function of IL-12p40 as a chemotactic molecule for macrophages. J Immunol (1999) 1.12
Basic fibroblast growth factor and de novo mammalian angiogenesis. Microvasc Res (1994) 1.09
CD14+CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scand J Immunol (2002) 1.09
Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb (2000) 1.09
Expressions and clinical significances of angiopoietin-1, -2 and Tie2 in human gastric cancer. Biochem Biophys Res Commun (2005) 1.07
Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer. Br J Urol (1998) 1.07
The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis. PLoS Pathog (2008) 1.06
Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol (2004) 1.05
Maintenance of clonal anergy by endogenously produced IL-10. Int Immunol (1994) 1.02
Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer. J Biomed Biotechnol (2010) 0.99
Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients. Scand J Gastroenterol (2002) 0.98
Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. J Biol Regul Homeost Agents (2001) 0.98
Interleukin-12. Int Arch Allergy Immunol (1995) 0.98
Urokinase plasminogen activator receptor (CD87) expression of tumor-associated macrophages in ductal carcinoma in situ, breast cancer, and resident macrophages of normal breast tissue. J Leukoc Biol (1999) 0.97
Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2001) 0.97
Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials (2012) 0.97
Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages. Clin Exp Immunol (1995) 0.94
CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol (2000) 0.94
Circulating vascular endothelial growth factor in patients with colorectal cancer. Am J Gastroenterol (1998) 0.92
Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers. Cytokine (2007) 0.91
A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int J Cancer (1990) 0.89
CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis. Clin Exp Immunol (2011) 0.87
Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response. Exp Cell Res (2012) 0.86
Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma. Dis Esophagus (2007) 0.85
Characterization of intracellular cytokine profile of CD4(+) T cells in peripheral blood and tumor-draining lymph nodes of patients with gastrointestinal cancer. Jpn J Clin Oncol (2000) 0.85
Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study. Radiother Oncol (2013) 1.50
Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity. Int J Oncol (2006) 1.09
Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer. Genes Chromosomes Cancer (2006) 1.05
Evaluation of the effects of mammography screening program on cancer progression and implemented treatment in patients with breast cancer. Pol Przegl Chir (2013) 0.95
Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression. Eur J Hum Genet (2010) 0.92
Inflammatory activation in children with primary hypertension. Pediatr Nephrol (2010) 0.90
Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins. J Cancer Res Clin Oncol (2009) 0.90
Evaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer. Contemp Oncol (Pozn) (2013) 0.86
Phenethyl isothiocyanate-induced cytoskeletal changes and cell death in lung cancer cells. Food Chem Toxicol (2012) 0.83
Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, and IL-1 beta mRNA expression. Eur J Gastroenterol Hepatol (2008) 0.82
Expression of cyclin B1 after induction of senescence and cell death in non-small cell lung carcinoma A549 cells. Folia Histochem Cytobiol (2012) 0.81
Immunologic properties differ in preterm infants fed olive oil vs soy-based lipid emulsions during parenteral nutrition. JPEN J Parenter Enteral Nutr (2008) 0.80
Actin cytoskeleton reorganization correlates with cofilin nuclear expression and ultrastructural changes in cho aa8 cell line after apoptosis and mitotic catastrophe induction by doxorubicin. Ultrastruct Pathol (2011) 0.80
Taxol-induced polyploidy and cell death in CHO AA8 cells. Acta Histochem (2008) 0.80
Polish consensus statement on the protective stoma. Pol Przegl Chir (2014) 0.79
Expression of cyclin A, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin. Cell Biol Int (2012) 0.79
Low-dose etoposide-treatment induces endoreplication and cell death accompanied by cytoskeletal alterations in A549 cells: Does the response involve senescence? The possible role of vimentin. Cancer Cell Int (2013) 0.79
Expression of adhesion and activation molecules on circulating monocytes in children with Helicobacter pylori infection. Helicobacter (2012) 0.78
Pediatric Helicobacter pylori infection and circulating T-lymphocyte activation and differentiation. Helicobacter (2011) 0.78
Generation and identification of thymic epithelial progenitor cells pTEC by in-vitro processing of human thymic fragments for allotransplantation. Fetal Pediatr Pathol (2011) 0.77
Hyperthermia induces cytoskeletal alterations and mitotic catastrophe in p53-deficient H1299 lung cancer cells. Acta Histochem (2012) 0.77
Synthesis and anti-inflammatory activity of hydrazide derivatives of 2-methylidene-1,4-dicarboxybutanoic acid. Acta Pol Pharm (2013) 0.77
Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences. Curr Hypertens Rep (2013) 0.77
Benign mesocolon schwannoma in PET/CT and immunohistochemistry assessment: a case report. Contemp Oncol (Pozn) (2012) 0.77
The effect of G-CSF on F-actin reorganization in HL-60 and K562 cell lines. Oncol Rep (2012) 0.76
Expression of cyclin D1 after treatment with doxorubicin in the HL-60 cell line. Cell Biol Int (2014) 0.76
Spinal cord hydrolysate ameliorate immunological reaction in experimental allergic encephalomyelitis. Acta Neurobiol Exp (Wars) (2009) 0.76
Differentiation of morphotic elements in human blood using optical coherence tomography and a microfluidic setup. Opt Express (2015) 0.76
Neutrophil phenotypic characteristics in children with congenital asplenia and splenectomized for hereditary spherocytosis. Immunol Invest (2011) 0.75
Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia. Medicine (Baltimore) (2015) 0.75
Post-zygotic and inter-individual structural genetic variation in a presumptive enhancer element of the locus between the IL10Rβ and IFNAR1 genes. PLoS One (2013) 0.75
Peripheral blood T lymphocyte subsets in children with congenital asplenia. Hum Immunol (2012) 0.75
Prevalence of biological types of breast cancer and their influence on disease staging and therapeutic management - a single-center study. Pol J Pathol (2017) 0.75
Cytoskeletal changes during cellular response of the A549 lung cancer cells to continuous cisplatin treatment. Cell Biol Int (2010) 0.75
Clinical significance of Van Nuys Prognostic Index as a qualification criterion to sentinel lymph node biopsy in patients diagnosed with ductal carcinoma in situ. Pol Przegl Chir (2015) 0.75
[Standardized surgical procedures for treating cancers of the colon, rectum and anus]. Pol J Pathol (2014) 0.75
[Skin cancer screening program in the population of Bydgoszcz]. Wiad Lek (2004) 0.75
Problems concerning patients' qualification for surgical procedures allowing for evaluation of the condition of axillary fossa lymph nodes in the radical treatment of breast cancer. Pol Przegl Chir (2015) 0.75
Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension. J Hypertens (2016) 0.75
Histopathological lesions in different types of skin aging. Acta Dermatovenerol Alp Pannonica Adriat (2010) 0.75
Application of immunohistochemistry for detection of metastases in sentinel lymph nodes of non-advanced breast cancer patients. Pol J Pathol (2015) 0.75
Activity of antioxidant enzymes in melanoma patients. Int J Dermatol (2013) 0.75